News & Views

Cancer screening

Survey Results Support Predicted Effects of Pandemic Screening Drop

Clinicians are already seeing an increase in late-stage cancer diagnoses that they attribute to the pandemic-driven pause in cancer screening and treatment adherence, according to the results of a survey from the American Society for Radiation Oncology.

Trending Topics

View All Topics

Oncology Drug Reference Sheet: Trilaciclib

Clinical practice

Oncology Drug Reference Sheet: Trilaciclib

Find Your Voice With ONS’s Leadership Development Committee

Find Your Voice With ONS’s Leadership Development Committee

FDA Grants Accelerated Approval to Amivantamab-Vmjw for Metastatic NSCLC

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Amivantamab-Vmjw for Metastatic NSCLC

What the Evidence Says For Dance/Movement Therapy in Cancer Care

Clinical practice

What the Evidence Says for Dance/Movement Therapy in Cancer Care

FDA Approves Nivolumab for Resected Esophageal or GEJ Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Nivolumab for Resected Esophageal or GEJ Cancer

Text Messaging Reduces Disparities in Colorectal Cancer Screening

Text Messaging Reduces Disparities in Colorectal Cancer Screening

The Case of the Weight Loss Wishes

Clinical practice

The Case of the Weight Loss Wishes

Targeted Therapies Are Transforming the Treatment of Non-Small Cell Lung Cancer

Targeted Therapies Are Transforming the Treatment of Non-Small Cell Lung Cancer

Electroacupuncture and Auricular Acupuncture for Chronic Musculoskeletal Pain in Cancer Survivors

Pain management

Electroacupuncture and Auricular Acupuncture for Chronic Musculoskeletal Pain in Cancer Survivors

Nursing Considerations for Melanoma Survivorship Care

Nursing Considerations for Melanoma Survivorship Care

Targeted Therapy Drug Shows Promise in CLL

Targeted Therapy Drug Shows Promise in CLL

Larotrectinib and Other Tumor-Agnostic Targeted Therapies Are Leading Cancer Care Into the Next Frontier

Targeted therapy

Larotrectinib and Other Tumor-Agnostic Targeted Therapies Are Leading Cancer Care Into the Next Frontier

Evidence-Based Leadership Trends Show How Every Nurse Is a Leader

Evidence-Based Leadership Trends Show How Every Nurse Is a Leader

Oncology Nursing Society Collaborates With Four Organizations to Develop Grief Resources

ONS Collaborates With Four Organizations to Develop Grief Resources

Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Cancers

Clinical practice

Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Cancers

FDA Grants Accelerated Approval to Pembrolizumab for HER2-Positive Gastric Cancer

Clinical practice

FDA Grants Accelerated Approval to Pembrolizumab for HER2-Positive Gastric Cancer

Genomics Test Guides Treatment Decisions for Prostate Cancer

Genetics & genomics

Genomics Test Guides Treatment Decisions for Prostate Cancer

Nursing Leadership Has Space for You and Your Goals

nursing professional development

Nursing Leadership Has Space for You and Your Goals

We Have So Much to Celebrate in Nursing and Cancer Science This Year

We Have So Much to Celebrate in Nursing and Cancer Science This Year

Time in Nature Is Time Well Spent

Nurse well-being

Time in Nature Is Time Well Spent

Gut Microbiome May Be a Factor With Immunotherapy Resistance in Advanced Melanoma

Gut Microbiome May Be a Factor With Immunotherapy Resistance in Advanced Melanoma

Oncology Drug Reference Sheet: Relugolix

Clinical practice

Oncology Drug Reference Sheet: Relugolix

What Oncology Nurses Need to Know About Telehealth

Nurse empowerment

What Oncology Nurses Need to Know About Telehealth

FDA Grants Accelerated Approval to Loncastuximab Tesirine-Lpyl for Large B-Cell Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Loncastuximab Tesirine-Lpyl for Large B-Cell Lymphoma

Oncology Nurses Receive Awards at the 46th Annual ONS Congress

Oncology Nurses Receive Awards at the 46th Annual ONS Congress

FDA Grants Accelerated Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer

Oncology drug research

FDA Grants Accelerated Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer

FDA Announces Recall of BD Alaris Pump Module Model 8100 Because of Risk of Stuck or Unresponsive Keys

U.S. Food and Drug Administration (FDA)

FDA Announces Several New Recalls of BD Alaris Pump Module Model 8100 Because of Key and Bezel Problems

Naproxen Improves Immune Response to Cancer in People With Lynch Syndrome

Naproxen Improves Immune Response to Cancer in People With Lynch Syndrome

The Case of the Transgender Considerations for Cancer Screening

Patient Support

The Case of the Transgender Considerations for Cancer Screening

ONS Members See Beyond Barriers and Understand Benefits of Guidelines

ONS Members See Beyond Barriers and Understand Benefits of Guidelines

FDA Approves Nivolumab in Combination With Chemotherapy for Metastatic Gastric Cancer and Esophageal Adenocarcinoma

Clinical practice

FDA Approves Nivolumab in Combination With Chemotherapy for Metastatic Gastric Cancer and Esophageal Adenocarcinoma

Meet Your ONS Leader: Teresa Knoop

Meet Your ONS Leader: Teresa Knoop

Surveys Show PPE Is Still in Short Supply

Personal protective equipment (PPE)

Surveys Show PPE Is Still in Short Supply

Betty Ferrell Receives 2021 ONS Lifetime Achievement Award

Betty Ferrell Receives 2021 ONS Lifetime Achievement Award

Onboarding and Supporting New Providers Are Your Responsibilities as an APRN Leader

Advanced Practice Nursing (APRN)

Onboarding and Supporting New Providers Are Your Responsibilities as an APRN Leader

FDA Grants Accelerated Approval to Sacituzumab Govitecan for Advanced Urothelial Cancer

Clinical practice

FDA Grants Accelerated Approval to Sacituzumab Govitecan for Advanced Urothelial Cancer

Latina, Asian Women With Gynecologic Cancers Are Less Likely to Use Palliative Care

Latina, Asian Women With Gynecologic Cancers Are Less Likely to Use Palliative Care

Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer

Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer

Involve the Entire Cancer Care Team to Effectively Implement Guidelines

Clinical practice guidelines

Involve the Entire Cancer Care Team to Effectively Implement Guidelines

The Case of the Targeted Therapy Toxicity

Genetics & genomics

The Case of the Targeted Therapy Toxicity

Nursing Considerations for Head and Neck Cancer Survivorship Care

Nursing Considerations for Head and Neck Cancer Survivorship Care

FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer

Clinical practice

FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer

Adding MRI to PSA Detects More Prostate Cancers Than PSA Alone

Adding MRI to PSA Detects More Prostate Cancers Than PSA Alone

FDA Approves New Cetuximab Dosing Regimen for Colorectal Cancer and Squamous Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves New Cetuximab Dosing Regimen for Colorectal Cancer and Squamous Cell Carcinoma

FDA Issues Safety Communication for ADM Products Used in Implant-Based Breast Reconstruction

Clinical practice

FDA Issues Safety Communication for ADM Products Used in Implant-Based Breast Reconstruction

New Guidelines in Cancer Care: How Nurses Have Implemented Them to Transform Practice

Clinical practice guidelines

New Guidelines in Cancer Care

Protecting Nurses and Patients and Advancing Practice Drive ONS Advocacy

Protecting Nurses and Patients and Advancing Practice Drive ONS Advocacy

In Case You Missed It: Here Are the Big ONS Changes in Recent Years

In Case You Missed It: Here Are the Big ONS Changes in Recent Years

FDA Approves Isatuximab-Irfc for Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Approves Isatuximab-Irfc for Multiple Myeloma

Back to Top ▲